Funding for this research was provided by:
the Lifeng Institute of Regenerative Medicine of Tongji University
major program of development fund for shanghai zhangjiang national innovation demonstration zone <stem cell strategic biobank and stem cell clinical technology transformation platform> (ZJ2018-ZD-004)
the peak disciplines (type iv) of institutions of higher learning in shanghai
Received: 29 June 2021
Accepted: 21 June 2022
First Online: 8 August 2022
: All human samples and animal studies were approved by the Committee of Ethics on Experimentation of Tongji University. The experiments were conducted following the National Institutes of Health guidelines for the care and use of animals.
: Not applicable.
: The authors declare that they have no competing interests.